CCCC vs CHD · rev $35.6M vs P/E 32, rev $6.11B
C4 Therapeutics Inc (CCCC) versus Church & Dwight Company Inc (CHD) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Church & Dwight Company Inc (CHD) is a household & personal products company listed on NYSE.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported CHD revenue for 2024-12-31 was $6.11B. Net income was $585.3M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
CCCC currently screens at market cap $425.7M. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
Not investment advice. Open the CCCC and CHD stock pages for the full models.
Not investment advice.